Literature DB >> 7611477

An NADPH oxidase superoxide-generating system in the rabbit aorta.

P J Pagano1, Y Ito, K Tornheim, P M Gallop, A I Tauber, R A Cohen.   

Abstract

Superoxide anion can modulate vascular smooth muscle tone and potentially affect the growth response in vascular disease. The present studies were undertaken to characterize the source of superoxide in rabbit aorta. Rings of aorta (5 mm) were incubated in physiological salt solution (PSS) for 30 min at 37 degrees C in the presence of 10 mM diethyldithiocarbamate (DDC) with or without inhibitors of superoxide-generating systems. Rings were then placed in PSS containing 250 microM lucigenin at 37 degrees C in the presence or absence of inhibitors, and changes in amounts of superoxide were determined by measuring chemiluminescence (units). The inhibitors of xanthine oxidase, oxypurinol (300 microM), and of mitochondrial NADH dehydrogenase, rotenone (50 microM), had no significant effect on superoxide levels. An inhibitor of NADPH oxidase, iodonium thiophen, caused a concentration-dependent inhibition of superoxide anion (12.49 +/- 1.48 vs 5.27 +/- 1.81 and 2.30 +/- 0.36 units, control vs 7 microM and 70 microM iodonium thiopen, respectively). A structurally related iodonium compound, diphenyleneiodonium (20 microM), caused a 78% reduction in basal and DDC-evoked superoxide levels. In the presence or absence of DDC, exogenous administration of NADPH (10 microM-1 mM), but not NADP (1 mM), elicited a concentration-dependent rise in superoxide levels that was inhibited by iodonium thiophen. Particulate fractions of whole aortic tissue exhibited NADPH-dependent superoxide production that was inhibited by 1 microM diphenyleneiodonium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611477     DOI: 10.1152/ajpheart.1995.268.6.H2274

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  49 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

Review 3.  Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.

Authors:  Richard A Cohen; XiaoYong Tong
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

4.  The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos.

Authors:  Jian Dong; Kathleen K Sulik; Shao-yu Chen
Journal:  Toxicol Lett       Date:  2009-12-21       Impact factor: 4.372

Review 5.  Cellular and molecular mechanisms of endothelial cell dysfunction.

Authors:  D G Harrison
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Authors:  Yao Sun; Jiakun Zhang; Li Lu; Sue S Chen; Mark T Quinn; Karl T Weber
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

7.  Transient hyperoxic reoxygenation reduces cytochrome C oxidase activity by increasing superoxide dismutase and nitric oxide.

Authors:  Amina Arab; Jin Wang; Kathrin Bausch; Katharina von Schmädel; Christoph Bode; Christoph Hehrlein
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

Review 8.  Enzymatic antioxidant system in vascular inflammation and coronary artery disease.

Authors:  Valter Lubrano; Silvana Balzan
Journal:  World J Exp Med       Date:  2015-11-20

Review 9.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

10.  NOX and inflammation in the vascular adventitia.

Authors:  Gábor Csányi; W Robert Taylor; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.